HK1080282A1 - Improved formulations containing substituted imidazole derivatives - Google Patents

Improved formulations containing substituted imidazole derivatives

Info

Publication number
HK1080282A1
HK1080282A1 HK05110140.3A HK05110140A HK1080282A1 HK 1080282 A1 HK1080282 A1 HK 1080282A1 HK 05110140 A HK05110140 A HK 05110140A HK 1080282 A1 HK1080282 A1 HK 1080282A1
Authority
HK
Hong Kong
Prior art keywords
sub
formulations containing
imidazole derivatives
substituted imidazole
containing substituted
Prior art date
Application number
HK05110140.3A
Other languages
English (en)
Inventor
Susan Banbury
Paivi Juujarvi
Leon P Grother
Walter Lunsmann
Owen Murray
Juha-Matti Savola
Original Assignee
Rp Scherer Technologies Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rp Scherer Technologies Llc filed Critical Rp Scherer Technologies Llc
Publication of HK1080282A1 publication Critical patent/HK1080282A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Inorganic Chemistry (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
HK05110140.3A 2002-11-08 2005-11-11 Improved formulations containing substituted imidazole derivatives HK1080282A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0226076.8A GB0226076D0 (en) 2002-11-08 2002-11-08 Improved formulations containing substituted imidazole derivatives
PCT/US2003/034934 WO2004043439A1 (en) 2002-11-08 2003-11-03 Improved formulations containing substituted imidazole derivatives

Publications (1)

Publication Number Publication Date
HK1080282A1 true HK1080282A1 (en) 2006-04-21

Family

ID=9947452

Family Applications (1)

Application Number Title Priority Date Filing Date
HK05110140.3A HK1080282A1 (en) 2002-11-08 2005-11-11 Improved formulations containing substituted imidazole derivatives

Country Status (16)

Country Link
US (1) US9717681B2 (xx)
EP (1) EP1581192B1 (xx)
JP (2) JP2006517516A (xx)
KR (1) KR101170548B1 (xx)
AU (1) AU2003287476B2 (xx)
CA (1) CA2503630C (xx)
ES (1) ES2392967T3 (xx)
GB (1) GB0226076D0 (xx)
HK (1) HK1080282A1 (xx)
IL (1) IL168257A (xx)
MX (1) MXPA05004745A (xx)
NO (1) NO336460B1 (xx)
NZ (1) NZ539731A (xx)
PL (1) PL214226B1 (xx)
RU (1) RU2349305C2 (xx)
WO (1) WO2004043439A1 (xx)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1890733B (zh) * 2003-12-01 2011-09-14 索尼株式会社 光盘用母盘的制造方法以及光盘用母盘
US7972621B2 (en) * 2004-06-03 2011-07-05 R.P. Scherer Technologies, Llc Process for formulating fast dispersing dosage forms comprising at least one fish gelatin selected on the basis of molecular weight
US8268791B2 (en) 2004-08-25 2012-09-18 Aegis Therapeutics, Llc. Alkylglycoside compositions for drug administration
WO2011026080A1 (en) 2009-08-31 2011-03-03 Wilmington Pharmaceuticals, Llc Fast disintegrating compositions of meloxicam, processes for preparation, and use to treat arthritis and/or pain
EP3332772A1 (en) 2009-10-30 2018-06-13 IX Biopharma Ltd Fast dissolving solid dosage form
US11672761B2 (en) 2020-11-16 2023-06-13 Orcosa Inc. Rapidly infusing platform and compositions for therapeutic treatment in humans

Family Cites Families (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB211423A (en) 1923-10-06 1924-02-21 Leopold Seeger Improved means for locking nuts
GB1548022A (en) * 1976-10-06 1979-07-04 Wyeth John & Brother Ltd Pharmaceutial dosage forms
IE45770B1 (en) * 1976-10-06 1982-11-17 Wyeth John & Brother Ltd Pharmaceutical dosage forms
NO852655L (no) * 1985-06-05 1986-12-08 Bio Data Corp Fremgangsmaate ved fremstilling av koaguleringsreagens for blodplasma i mikrokonsentrert tablettform.
US4855326A (en) * 1987-04-20 1989-08-08 Fuisz Pharmaceutical Ltd. Rapidly dissoluble medicinal dosage unit and method of manufacture
JPH02121919A (ja) * 1988-10-28 1990-05-09 Grelan Pharmaceut Co Ltd 柔軟性を有する錠剤
GB2225782A (en) * 1988-12-09 1990-06-13 Farmos Group Limited Imidazole derivatives useful for treatment of diabetes
US4968692A (en) * 1989-01-06 1990-11-06 The Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services Attenuation of ethyl alcohol intoxication with alpha-2 adrenoceptor antagonists
US4946684A (en) * 1989-06-20 1990-08-07 American Home Products Corporation Fast dissolving dosage forms
US5079018A (en) * 1989-08-14 1992-01-07 Neophore Technologies, Inc. Freeze dry composition and method for oral administration of drugs, biologicals, nutrients and foodstuffs
WO1991004757A1 (en) 1989-10-02 1991-04-18 Cima Labs, Inc. Effervescent dosage form and method of administering same
GB9127050D0 (en) 1991-12-20 1992-02-19 Orion Yhtymae Oy Substituted imidazole derivatives and their preparation and use
RU2109509C1 (ru) 1991-12-24 1998-04-27 Яманути Фармасьютикал Ко., Лтд. Композиция для буккального введения лекарственного средства и способ ее получения
US5298261A (en) * 1992-04-20 1994-03-29 Oregon Freeze Dry, Inc. Rapidly distintegrating tablet
GB9312669D0 (en) * 1993-06-18 1993-08-04 Orion Yhtymae Oy New opticla isomers
US6726928B2 (en) * 1994-10-28 2004-04-27 R.P. Scherer Technologies, Inc. Process for preparing solid dosage forms for unpalatable pharmaceuticals
GB9517062D0 (en) * 1995-08-18 1995-10-25 Scherer Ltd R P Pharmaceutical compositions
AU733032C (en) 1996-06-14 2002-01-03 Kyowa Hakko Kirin Co., Ltd. Intraorally rapidly disintegrable tablet
DE19646392A1 (de) * 1996-11-11 1998-05-14 Lohmann Therapie Syst Lts Zubereitung zur Anwendung in der Mundhöhle mit einer an der Schleimhaut haftklebenden, Pharmazeutika oder Kosmetika zur dosierten Abgabe enthaltenden Schicht
US5976577A (en) * 1997-07-11 1999-11-02 Rp Scherer Corporation Process for preparing fast dispersing solid oral dosage form
FR2781152B1 (fr) 1998-07-20 2001-07-06 Permatec Tech Ag Utilisation d'un polymere de type acrylique en tant qu'agent de desagregation
JP2000095674A (ja) * 1998-09-22 2000-04-04 Sato Pharmaceutical Co Ltd 口腔内崩壊時間短縮化錠剤の製造方法及び装置
US6552024B1 (en) * 1999-01-21 2003-04-22 Lavipharm Laboratories Inc. Compositions and methods for mucosal delivery
GB9908014D0 (en) * 1999-04-08 1999-06-02 Scherer Corp R P Pharmaceutical compositions
GB9910505D0 (en) 1999-05-06 1999-07-07 Electrosols Ltd A method and apparatus for manufacturing consumable tablets
US6284270B1 (en) * 1999-08-04 2001-09-04 Drugtech Corporation Means for creating a mass having structural integrity
FR2798289B1 (fr) 1999-09-15 2004-12-31 Cll Pharma Formes galeniques a delitement rapide en bouche et leur procede de preparation
US6375982B1 (en) * 2000-07-05 2002-04-23 Capricorn Pharma, Inc. Rapid-melt semi-solid compositions, methods of making same and method of using same
ATE536869T1 (de) 2001-10-12 2011-12-15 Monosolrx Llc Auf glucan-film basierte wirkstoffverabreichungssysteme

Also Published As

Publication number Publication date
EP1581192A1 (en) 2005-10-05
NO20052360L (no) 2005-06-06
AU2003287476A1 (en) 2004-06-03
KR20050086458A (ko) 2005-08-30
GB0226076D0 (en) 2002-12-18
AU2003287476B2 (en) 2008-11-20
WO2004043439A1 (en) 2004-05-27
NO336460B1 (no) 2015-08-31
PL214226B1 (pl) 2013-07-31
US20060134194A1 (en) 2006-06-22
MXPA05004745A (es) 2005-08-03
CA2503630C (en) 2013-07-30
JP2006517516A (ja) 2006-07-27
PL375565A1 (en) 2005-11-28
EP1581192A4 (en) 2009-12-02
RU2005117626A (ru) 2006-01-20
EP1581192B1 (en) 2012-08-08
JP2012051941A (ja) 2012-03-15
IL168257A (en) 2014-04-30
US9717681B2 (en) 2017-08-01
KR101170548B1 (ko) 2012-08-01
ES2392967T3 (es) 2012-12-17
JP5474033B2 (ja) 2014-04-16
CA2503630A1 (en) 2004-05-27
NZ539731A (en) 2008-06-30
RU2349305C2 (ru) 2009-03-20

Similar Documents

Publication Publication Date Title
AP1965A (en) Tropane derivatives useful in therapy.
DE68917023D1 (de) 3-Pyrrolidinylthio-1-azabicyclo[3.2.0]-hept-2-en-2-carbonsäureverbindungen.
ATE107306T1 (de) 3-pyrrolidinylthio-1-azabicyclo (3.2.0)hept-2-en- 2-carbonsäure-verbindungen.
IL150883A0 (en) Pyrimidine compounds
ATE349432T1 (de) 2-anilino-pyrimidin-derivate als cyclin-abhängige kinase hemmer
ZA89986B (en) 3-alkenyl-1-azabicyclo(3.2.0)hept-2-ene-2-carboxylic acid compounds
NO20062004L (no) Forlenget frigjoring farmasoytiske blandinger omfattene aplindor og derivater derav
EP1775283A4 (en) 3-AMINOBENZAMIDE COMPOUND AND INHIBITORS OF THE ACTIVITY OF VANILLOID RECEPTOR 1 (VR1)
WO2002010154A3 (en) Substituted heterocyclic amides
EP1340755A4 (en) AGENT WITH EFFECT AGAINST HELICOBACTER
DE69827236D1 (en) Matrix-metalloproteinase-hemmer
MXPA02003977A (es) Inhibidores de adhesion de celula mediada por al°2.
NZ196284A (en) 1-piperazino-3-phenylindane derivatives:pharmaceutical compositions
HK1080282A1 (en) Improved formulations containing substituted imidazole derivatives
AU2003228678A1 (en) 1-substituted imidazole derivatives as nos inhibitors
AU7517400A (en) N-substituted 4-aminopteridines, synthesis and use thereof as pharmaceutical agent
BRPI0409959A (pt) uso de derivados de azetidinacarboxamida em terapia
DE69015736D1 (de) 7-Keto- und 7-Hydroxy-androsta-3,5-dien-3-carbonsäure Derivate.
TW200745033A (en) Oxindole derivative as feeding control agent
CA2238875A1 (en) Tri-aryl ethane derivatives as pde iv inhibitors
PL378201A1 (pl) Sposób farmaceutyczny oraz związki wytwarzane tym sposobem
PL359415A1 (en) Oxadiazole derivatives having anticancer effects
AU8811401A (en) Spiro compounds and adhesion molecule inhibitors containing the same as the active ingredient
NO20060277L (no) Anvendelse av bisyklo [2.2.1] heptanderivater til fremstilling av nevrobeskyttende farmasoytiske sammensetninger
DE60114640D1 (en) Antithrombosemittel

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20191030